Breaking News Instant updates and real-time market news.

LOGM

LogMeln

$133.80

3.6 (2.77%)

16:22
02/15/18
02/15
16:22
02/15/18
16:22

LogMeln down 3.6% after reporting Q4 results, giving Q1, FY18 guidance

  • 15

    Feb

  • 14

    Mar

LOGM LogMeln
$133.80

3.6 (2.77%)

12/19/17
JPMS
12/19/17
NO CHANGE
Target $145
JPMS
Overweight
LogMeln cash flow, capital return outlook warrants buying, says JPMorgan
JPMorgan analyst Sterling Auty notes LogMeIn stock reacted negatively on management's 2018 and 2020 outlook for revenue growth as expectations were elevated into the event. However, the analyst thinks this is "a knee-jerk reaction" to a number and not really the market seeing that the fundamentals are still moving in the right direction, given "solid" growth, expanding margins and capital return. Auty reiterates an Overweight rating and $145 price target on the shares.
12/20/17
PIPR
12/20/17
NO CHANGE
Target $150
PIPR
Overweight
LogMeln outlook not directly comparable to consensus, says Piper Jaffray
Piper Jaffray analyst Alex Zukin says that since LogMeln is no longer incorporating acquisitions into its outlook, yesterday's guidance is not perfectly comparable to consensus estimates. The analyst views both the 2018 outlook and three-year targets issued at yesterday's analyst day as conservative. He sees "significant valuation support" from free cash flow following yesterday's 3% pullback and keeps an Overweight rating on LogMeln. The analyst, however, lowered his price target for the shares to $150 from $183.
12/20/17
NEED
12/20/17
NO CHANGE
Target $130
NEED
Buy
LogMeln price target lowered to $130 at Needham after analyst day
After attending LogMeln's analyst day meeting, Needham analyst Richard Valera noted that the organic revenue growth targets put forward were below what he and the Street had been expecting and he cut his price target on the stock to $130 from $135. However, he said he suspects the targets "embed some of the company's historical conservatism" and noted that its EBITDA targets remain largely inline with prior expectations. Valera keeps a Buy rating on LogMeIn shares.
02/08/18
JPMS
02/08/18
NO CHANGE
JPMS
Overweight
LogMeln acquisition of Jive positive for shareholders, says JPMorgan
JPMorgan analyst Sterling Auty views LogMeln's (LOGM) acquisition of Jive Communications for $342M in cash as positive for both growth and shareholders. The deal will add needed top-line growth, bolster the overall platform, and capitalize on the "robust" unified communications as a service market, Auty tells investors in a research note. He sees LogMeln benefitting as competitors RingCentral (RNG) and 8x8, Inc. (EGHT) focus on moving into the large enterprise segment. The analyst keeps an Overweight rating on LogMeln.

TODAY'S FREE FLY STORIES

CCL

Carnival

$56.32

-0.28 (-0.49%)

09:30
12/17/18
12/17
09:30
12/17/18
09:30
Upgrade
Carnival rating change  »

Carnival upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

CNC

Centene

$127.55

-5.3 (-3.99%)

09:30
12/17/18
12/17
09:30
12/17/18
09:30
Recommendations
Centene analyst commentary  »

BMO says Centene's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

ALTM

Altus Midstream Company

$8.72

-0.71 (-7.53%)

09:30
12/17/18
12/17
09:30
12/17/18
09:30
Hot Stocks
Breaking Hot Stocks news story on Altus Midstream Company »

Altus Midstream Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$365.69

-11.17 (-2.96%)

, AAPL

Apple

$165.48

-5.45 (-3.19%)

09:26
12/17/18
12/17
09:26
12/17/18
09:26
Periodicals
Designer Andrew Kim departs Tesla to join Apple, The Verge reports »

Tesla (TSLA) senior…

TSLA

Tesla

$365.69

-11.17 (-2.96%)

AAPL

Apple

$165.48

-5.45 (-3.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTSX

Point 360

$0.00

(0.00%)

09:25
12/17/18
12/17
09:25
12/17/18
09:25
Hot Stocks
Court approves Point 360 second amended disclosure statement »

Point.360 announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$24.49

0.1 (0.41%)

09:24
12/17/18
12/17
09:24
12/17/18
09:24
Hot Stocks
Bank of America reports November card write-offs 2.68% vs. 2.43% last month »

Reports November 30-plus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

IBTX

Independent Bank

$47.72

-1.6 (-3.24%)

, GBNK

Guaranty Bancorp

$21.44

-0.65 (-2.94%)

09:24
12/17/18
12/17
09:24
12/17/18
09:24
Hot Stocks
Independent Bank receives regulatory approval for Guaranty Bancorp merger »

Independent Bank (IBTX)…

IBTX

Independent Bank

$47.72

-1.6 (-3.24%)

GBNK

Guaranty Bancorp

$21.44

-0.65 (-2.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

09:22
12/17/18
12/17
09:22
12/17/18
09:22
Conference/Events
UBS retail analyst to hold an analyst/industry conference call »

Retail Analyst Sole…

MDT

Medtronic

$93.78

-1.7 (-1.78%)

09:22
12/17/18
12/17
09:22
12/17/18
09:22
Hot Stocks
Medtronic announces FDA approval of InterStim programmer »

Medtronic announced FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMAR

Smartsheet

$24.78

0.8 (3.34%)

09:21
12/17/18
12/17
09:21
12/17/18
09:21
Recommendations
Smartsheet analyst commentary  »

William Blair remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 20

    Dec

SWGAY

Swatch Group

$0.00

(0.00%)

09:20
12/17/18
12/17
09:20
12/17/18
09:20
Downgrade
Swatch Group rating change  »

Swatch Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:20
12/17/18
12/17
09:20
12/17/18
09:20
General news
U.S. equities continue to backtrack »

U.S. equities continue to…

GNUS

Genius Brands

$2.38

(0.00%)

09:19
12/17/18
12/17
09:19
12/17/18
09:19
Hot Stocks
Genius Brands licenses rights to Gershwin Entertainment for Rainbow Rangers live »

Genius Brands new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZEN

Zendesk

$59.93

-1.26 (-2.06%)

09:19
12/17/18
12/17
09:19
12/17/18
09:19
Recommendations
Zendesk analyst commentary  »

Zendesk shares can offer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 20

    Dec

NTRP

Neurotrope

$4.08

-0.18 (-4.23%)

09:18
12/17/18
12/17
09:18
12/17/18
09:18
Syndicate
Neurotrope announces $22.5M registered direct offering »

Neurotrope announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
12/17/18
12/17
09:18
12/17/18
09:18
Options
Overnight activity included 611 trades in SPX and 21 trades in VIX »

611 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:17
12/17/18
12/17
09:17
12/17/18
09:17
Conference/Events
UBS U.S. Internet analyst to hold an analyst/industry conference call »

U.S. Internet Analyst…

CUTR

Cutera

$16.49

-0.6 (-3.51%)

09:16
12/17/18
12/17
09:16
12/17/18
09:16
Hot Stocks
Cutera announces FDA approval of new indication for enlighten laser platform »

Cutera announced the FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASH

Ashland

$72.92

-1.52 (-2.04%)

09:16
12/17/18
12/17
09:16
12/17/18
09:16
Initiation
Ashland initiated  »

Ashland initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HON

Honeywell

$136.40

-2.39 (-1.72%)

09:16
12/17/18
12/17
09:16
12/17/18
09:16
Hot Stocks
Honeywell announces new e-commerce platform 'GoDirect Trade' »

Honeywell is bringing the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

GS

Goldman Sachs

$172.80

-3.07 (-1.75%)

, EVFM

Evofem

$3.50

-0.28 (-7.41%)

09:16
12/17/18
12/17
09:16
12/17/18
09:16
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Evofem (EVFM), up…

GS

Goldman Sachs

$172.80

-3.07 (-1.75%)

EVFM

Evofem

$3.50

-0.28 (-7.41%)

AXON

Axovant Sciences

$1.01

-0.12 (-10.62%)

BKS

Barnes & Noble

$6.49

-0.17 (-2.55%)

JACK

Jack in the Box

$80.22

-2.27 (-2.75%)

WFT

Weatherford

$0.43

-0.0258 (-5.61%)

BBY

Best Buy

$55.37

-0.56 (-1.00%)

THC

Tenet

$21.24

-2.25 (-9.58%)

CNC

Centene

$127.55

-5.3 (-3.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 05

    Feb

  • 19

    Feb

PSTI

Pluristem

$0.85

-0.0607 (-6.67%)

09:15
12/17/18
12/17
09:15
12/17/18
09:15
Hot Stocks
Pluristem provides recap of KOL meeting on PAD »

Pluristem provided a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:15
12/17/18
12/17
09:15
12/17/18
09:15
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

MAXR

Maxar Technologies

$12.47

-0.39 (-3.03%)

09:14
12/17/18
12/17
09:14
12/17/18
09:14
Hot Stocks
Maxar's MDA, Orbital Insight expand SAR satellite imagery agreement »

MDA, a Maxar Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RMD

ResMed

$112.85

-2.54 (-2.20%)

09:13
12/17/18
12/17
09:13
12/17/18
09:13
Hot Stocks
ResMed subsidiary Brightree acquires Apacheta, terms not disclsoed »

Brightree announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.